// App-Quantinova.ai

: Incidence of Central Nervous System Toxicity and Cytokine Release Syndrome in Leukemia Patients Treated with Blinatumomab

Researchers

Presenter

  • Elias Jabbour

Principal Investigators

  • Shilpa Paul

  • Dan E. Nichols

  • Faezeh Darbaniyan

  • Jenessa Lee

  • Koji Sasaki

  • Nicholas Short

  • Nitin Jain

  • Farhad Ravandi

  • Guillermo Garcia-Manero

  • Tapan M. Kadia

  • Guillermo Montalban-Bravo

  • Gautham Borthakur

  • Rebecca Garris

  • Marina Konopleva

  • Hagop Kantarjian

Medical Centers

  • MD Anderson Cancer Center, Houston, TX

  • Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston

  • Department of Leukemia, MD Anderson Cancer Center, Houston, TX

  • Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Cytokine release syndrome

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Cytokine

  • Twist-related protein 1

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved